Jubilant Life Sciences Ltd announces financial results for the quarter
The Board of Jubilant Life Sciences Limited, an integrated pharmaceutical and life sciences company met today to approve financial results […]
Tags: business, Business/Finance, Chairman & Managing Director, China, Co-Chairman & Managing Director, Earnings before interest taxes depreciation and amortization, Economy of India, europe, FDA, Finance, Health/Medical/Pharmaceuticals, Healthcare in India, income, investment, Japan, JUBILANT LIFE SCIENCES LIMITED, Montreal, North America, pharmaceutical, Pharmaceutical industry in India, Quality System, radiopharmaceuticals, Reorganization, Rs, Shyam S Bhartia
Advances in Diagnostic Nuclear Medicine
[This article was published in the December 2008 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
Nuclear medicine is a branch of medicine and medical imaging that uses the nuclear properties of matter in diagnosis and therapy
Siemens to Launch PETNET Services in India
Siemens Healthcare has announced its first molecular imaging biomarker production facility in Chennai, India. The new facility will enable the healthcare providers in and around Chennai to access the positron emission tomography-computed tomography (PET-CT) technology to diagnose patients with life-threatening diseases, such as cancer and cardiac and neurological ailments.
NEWS REVIEW – INDIA
[This article was published in the November 2007 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
News Review
